Shah Nikita — SEC Form 4 filings
SEC reporting owner CIK 1738061. 13 Form 4 filings on record with FilingPulse; latest filed 2026-08-13.
Transaction summary — filings shown
Covers all 13 filings on record, filed 2024-02-29 to 2026-08-13. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 8 legs across 7 filings — 669,925 shares, $7,566,981 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 52.
- Largest priced transaction: sale of 146,403 shares @ $17.51 ($2,563,517) in Amneal Pharmaceuticals, Inc., filed 2026-08-13.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Amneal Pharmaceuticals, Inc. (AMRX) | Executive Vice President | 13 | — | 8 legs · 669,925 sh · $7,566,981 | 52 |
Form 4 filings — Shah Nikita
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-13 | 4 | Amneal Pharmaceuticals, Inc. (AMRX) | Sale (S): 146,403 @ $17.51 | EDGAR |
| 2026-03-05 | 4 | Amneal Pharmaceuticals, Inc. (AMRX) | Option exercise (M): 36,232 · Tax withholding (F): 18,502 @ $13.31 · Option exercise (M): 45,871 · Tax withholding (F): 22,982 @ $13.31 · Option exercise (M): 23,544 · Tax withholding (F): 11,796 @ $13.31 · +9 more | EDGAR |
| 2026-03-03 | 4 | Amneal Pharmaceuticals, Inc. (AMRX) | Grant/award (A): 65,359 (derivative) @ $0 · Grant/award (A): 65,359 (derivative) @ $0 | EDGAR |
| 2025-11-14 | 4 | Amneal Pharmaceuticals, Inc. (AMRX) | Option exercise (M): 36,331 @ $2.75 · Option exercise (M): 95,525 @ $2.75 · Sale (S): 131,856 @ $11.92 · Option exercise (M): 36,331 (derivative) @ $0 · Option exercise (M): 95,525 (derivative) @ $0 | EDGAR |
| 2025-08-25 | 4 | Amneal Pharmaceuticals, Inc. (AMRX) | Sale (S): 114,492 @ $9.66 · Sale (S): 6,340 @ $9.50 | EDGAR |
| 2025-08-15 | 4 | Amneal Pharmaceuticals, Inc. (AMRX) | Sale (S): 71,694 @ $9.29 | EDGAR |
| 2025-08-13 | 4 | Amneal Pharmaceuticals, Inc. (AMRX) | Sale (S): 50,000 @ $9.04 | EDGAR |
| 2025-05-19 | 4 | Amneal Pharmaceuticals, Inc. (AMRX) | Sale (S): 49,140 @ $7.58 | EDGAR |
| 2025-03-05 | 4 | Amneal Pharmaceuticals, Inc. (AMRX) | Option exercise (M): 36,232 · Tax withholding (F): 18,533 @ $8.76 · Option exercise (M): 45,872 · Tax withholding (F): 23,464 @ $8.76 · Option exercise (M): 144,928 · Tax withholding (F): 74,131 @ $8.76 · +8 more | EDGAR |
| 2025-03-04 | 4 | Amneal Pharmaceuticals, Inc. (AMRX) | Option exercise (M): 28,958 · Tax withholding (F): 10,985 @ $8.67 · Option exercise (M): 28,958 (derivative) @ $0 | EDGAR |
| 2024-08-16 | 4 | Amneal Pharmaceuticals, Inc. (AMRX) | Sale (S): 100,000 @ $7.75 | EDGAR |
| 2024-03-05 | 4 | Amneal Pharmaceuticals, Inc. (AMRX) | Option exercise (M): 28,957 · Tax withholding (F): 15,181 @ $5.47 · Option exercise (M): 36,232 · Tax withholding (F): 18,153 @ $5.47 · Option exercise (M): 45,871 · Tax withholding (F): 22,982 @ $5.47 · +5 more | EDGAR |
| 2024-02-29 | 4 | Amneal Pharmaceuticals, Inc. (AMRX) | Option exercise (M): 35,620 · Tax withholding (F): 18,670 @ $5.71 · Option exercise (M): 35,620 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1738061 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →